7H-PYRROLO[2,3-D]PYRIMIDINE-4-AMINE DERIVATIVE

The present invention provides a novel compound inhibiting EGFR or a salt of the compound. According to one embodiment of the present invention, provided is a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof. La presente invención provee un compuesto novedoso...

Full description

Saved in:
Bibliographic Details
Main Authors YAMAMOTO Fuyuki, KOBAYAKAWA Yu, HARA Shoki, FUCHIDA Hirokazu, KASUGA Hidefumi, MIZUTANI Takashi, OGINO Yoshio
Format Patent
LanguageEnglish
Spanish
Published 08.09.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a novel compound inhibiting EGFR or a salt of the compound. According to one embodiment of the present invention, provided is a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof. La presente invención provee un compuesto novedoso que inhibe el EGFR o una sal del compuesto; de conformidad con una modalidad de la presente invención, se provee un compuesto representado por la fórmula general (I) o una sal farmacéuticamente aceptable del mismo. (ver Fórmula).
Bibliography:Application Number: MX2021009752